ACXP
Acurx Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.39
+0.00%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
-7.6%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Apr 22, 2026 | LUCI DAVID P · director, officer: President and CEO | A-Award | 37,100 | $2.36 |
| Apr 22, 2026 | Scodari Joseph C · director | A-Award | 2,150 | $2.36 |
| Apr 22, 2026 | HARRISON THOMAS L · director | A-Award | 2,150 | $2.36 |
| Apr 22, 2026 | Donohue James J. · director | A-Award | 2,150 | $2.36 |
| Apr 22, 2026 | DEAN JACK H · director | A-Award | 2,150 | $2.36 |
| Apr 22, 2026 | Sailer Carl · director | A-Award | 2,150 | $2.36 |
| Apr 22, 2026 | Shawah Robert G. · officer: Chief Financial Officer | A-Award | 25,900 | $2.36 |
| Apr 22, 2026 | DELUCCIA ROBERT J · director | A-Award | 37,100 | $2.36 |
| Feb 6, 2025 | LUCI DAVID P · director, 10 percent owner, officer: President and CEO | A-Award | 250,000 | $0.80 |
| Feb 6, 2025 | Shawah Robert G. · officer: Chief Financial Officer | A-Award | 145,500 | $0.80 |
| Feb 6, 2025 | DELUCCIA ROBERT J · director, 10 percent owner: | A-Award | 250,000 | $0.80 |
| Jan 8, 2025 | Donohue James J. · director | Purchase | 9,852 | $1.01 |
| Jan 8, 2025 | Scodari Joseph C · director | Purchase | 24,631 | $1.01 |
| Jan 8, 2025 | Sailer Carl · director | Purchase | 24,631 | $1.01 |
| Jan 8, 2025 | LUCI DAVID P · director, 10 percent owner, officer: President and CEO | Purchase | 49,261 | $1.01 |
| Jan 8, 2025 | DELUCCIA ROBERT J · director, 10 percent owner: | Purchase | 49,261 | $1.01 |
| Jan 8, 2025 | DEAN JACK H · director | Purchase | 9,852 | $1.01 |
| Jun 18, 2024 | DEAN JACK H · director | A-Award | 12,000 | $2.38 |
| Jun 18, 2024 | Scodari Joseph C · director | A-Award | 12,000 | $2.38 |
| Jun 18, 2024 | Sailer Carl · director | A-Award | 12,000 | $2.38 |
| Jun 18, 2024 | HARRISON THOMAS L · director | A-Award | 12,000 | $2.38 |
| Jun 18, 2024 | Donohue James J. · director | A-Award | 12,000 | $2.38 |
| Apr 3, 2024 | Shawah Robert G. · officer: Chief Financial Officer | A-Award | 145,000 | $3.15 |
| Apr 3, 2024 | LUCI DAVID P · director, 10 percent owner, officer: President and CEO | A-Award | 250,000 | $3.15 |
| Apr 3, 2024 | DELUCCIA ROBERT J · director, 10 percent owner: | A-Award | 250,000 | $3.15 |
| Jan 22, 2024 | Sailer Carl · director | M-Exempt | 19,737 | $3.55 |
| Jan 4, 2024 | LUCI DAVID P · director, 10 percent owner, officer: President and CEO | M-Exempt | 19,737 | $3.55 |
| Jan 4, 2024 | DELUCCIA ROBERT J · director, 10 percent owner: | M-Exempt | 19,737 | $3.55 |
| Jun 16, 2023 | DEAN JACK H · director | A-Award | 10,000 | $2.75 |
| Jun 16, 2023 | Sailer Carl · director | A-Award | 10,000 | $2.75 |
Institutional positioning
13F filings over the trailing two quarters
New 10Increased 6Reduced 9Sold out 4
| Filer | Action | Shares | Filed |
|---|---|---|---|
| JANE STREET GROUP, LLC | Increased | 54,642 | May 12, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Unchanged | 31,099 | Aug 13, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 31,099 | May 15, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 26,411 | Aug 12, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 24,819 | May 15, 2026 |
| CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC. | New Position | 20,000 | Apr 30, 2026 |
| VANGUARD FIDUCIARY TRUST CO | Unchanged | 16,205 | Aug 13, 2026 |
| VANGUARD FIDUCIARY TRUST CO | New Position | 16,205 | May 8, 2026 |
| JANE STREET GROUP, LLC | Reduced | 15,727 | Aug 14, 2026 |
| PROSPECT FINANCIAL SERVICES LLC | Reduced | 13,785 | Apr 24, 2026 |
| Prospect Financial Services LLC | Unchanged | 13,785 | Aug 6, 2026 |
| MORGAN STANLEY | Increased | 7,500 | Aug 13, 2026 |
| MORGAN STANLEY | Reduced | 6,500 | May 15, 2026 |
| UBS GROUP AG | Increased | 6,312 | May 5, 2026 |
| Integrated Wealth Concepts LLC | New Position | 4,729 | Aug 12, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Apr 22, 2026